[
  {
    "ts": null,
    "headline": "Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers",
    "summary": "Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Exact Sciences (NASDAQ:EXAS) and its peers.",
    "url": "https://finnhub.io/api/news?id=7faeba0772a36a3f79896c2dce0bb40d30625f927b7c55559e5ac3d655a5348e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744707776,
      "headline": "Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers",
      "id": 133922389,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Exact Sciences (NASDAQ:EXAS) and its peers.",
      "url": "https://finnhub.io/api/news?id=7faeba0772a36a3f79896c2dce0bb40d30625f927b7c55559e5ac3d655a5348e"
    }
  }
]